Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
503
Total raised
£3.8B
disclosed amounts
This month
£36.9M
raised so far
Affirma Capital led the round to support new market entry and safety technology development.
"Micromobility has taken cutting edge safety systems such as Beam’s MARS technology and implemented them onto small electric vehicles such as e-scooters, e-bikes, and e-mopeds to help cities flow better for everyone. We are extremely excited to partner with a visionary fund such as Affirma Capital to bring lower cost, greener, and safer mobility for cities across APAC."
The round was led by Deepbridge Capital to help manufacture trial units for a new urinary tract infection diagnostic device.
"FluoretiQ perfectly represents the type of highly innovative and growth-focused companies Deepbridge Capital is committed to supporting within the sector-specific Deepbridge Life Sciences EIS fund; a great example of the importance of the Enterprise Investment Scheme. Neciah has built a great team, eager to take on the significant challenge this market demands, and we are pleased to be working with them on this next exciting stage of their journey."
The seed round was led by serial healthcare entrepreneurs Maurice Ferre and Arjun Desai to support expansion across the UK, Europe, and the US.
"More and more research shows the"
British Design Fund backs Cornwall-based start-up creating breathable and decorative breast prostheses.
"Following surgery for breast cancer, my mum was given a breast prosthesis to wear. It was hot, it made her sweaty and was uncomfortable against her scar. It was also heavy and pulled her clothing down when she moved. So in the end she refused to wear it. But there were times when she felt it would be nice to have some shape under her clothes and we really struggled to find any alternatives."
The Cambridge biotechnology company has raised £31.4m from investors including M&G and Amadeus Capital Partners to advance its desktop protein printer.
"There’s a fundamental productivity problem in biotech today. A biotech scientist needs to know how to make proteins to design drugs. That’s like expecting a computer scientist to know how to build a computer to design software,"
